Efficacy of Probiotics Compared With Pharmacological Treatments for Maintenance Therapy for Functional Constipation

Rebecca G Harris1,2, Elizabeth P Neale1,2, Marijka Batterham2,3

  • 1School of Medical Indigenous and Health Science, Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, New South Wales 2522, Australia.

Nutrition Reviews
|September 30, 2024
PubMed

Insights

Probiotics do not effectively treat functional constipation in children as a standalone therapy. Mineral oil and polyethylene glycol are more effective for improving bowel movements and treatment success.

Area of Science:

  • Pediatric Gastroenterology
  • Evidence-Based Medicine
  • Pharmacological Interventions

Background:

  • Increasing randomized controlled trials (RCTs) compare probiotics with conventional therapies for pediatric functional constipation.
  • Existing research lacks a comprehensive comparison and ranking of these treatments.

Purpose of the Study:

  • To conduct a network meta-analysis comparing probiotics against other oral maintenance therapies for functional constipation in children.
  • To rank all treatments based on their effectiveness.

Main Methods:

  • Systematic literature search across major databases (MEDLINE, Scopus, EMBASE, Cochrane Library) and trial registries.
  • Risk of bias assessed using Cochrane Risk of Bias 2 tool; confidence in estimates evaluated with the CINeMA framework.
  • Random-effects network meta-analyses performed for defecation frequency and treatment success.

Main Results:

  • Probiotics showed no significant increase in bowel movements compared to conventional treatments or placebo.
  • Mineral oil and a polyethylene glycol-lactulose combination were most effective for treatment success.
  • Mineral oil combined with probiotics was most effective for increasing defecation frequency.

Conclusions:

  • Current evidence does not support probiotics as a standalone treatment for pediatric functional constipation.
  • Mineral oil and polyethylene glycol are recommended as first-line treatments.
  • Further high-quality studies are needed to explore probiotics as adjunctive therapy.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
140
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
186
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
151
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
172
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
118
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
221